Clinical Trials Logo

Electronic Cigarettes clinical trials

View clinical trials related to Electronic Cigarettes.

Filter by:
  • None
  • Page 1

NCT ID: NCT05587504 Recruiting - Clinical trials for Electronic Cigarettes

Determination of Liquid Flavor and Nicotine Form Outcomes

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out how different types of electronic cigarette/vape e-liquids with differing sweetness and forms of nicotine affect blood nicotine levels, use behavior (how people puff), and how people feel.

NCT ID: NCT03861078 Completed - Clinical trials for Electronic Cigarettes

The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

Start date: February 17, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine differences in nicotine delivery, user behaviors, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with different nicotine (and sweetener) concentrations relative to using their own brand of cigarettes.

NCT ID: NCT03830892 Terminated - Clinical trials for Electronic Cigarettes

Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers

Start date: January 18, 2019
Phase: N/A
Study type: Interventional

This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.

NCT ID: NCT03742817 Completed - Clinical trials for Electronic Cigarettes

Effects of e-Cigarettes on Perceptions and Behavior

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal across young adult e-cigarette users and middle-age/older adult smokers with an interest in, but no significant experience with, e-cigarettes; (2) Determine which dimensions of e-cigarette product diversity differentially affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers with an interest in, but no significant experience with, e-cigarettes; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For Aim 1, young adult vapers (N=200) and adult smokers (N=200) will attend one laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, pg/vg ratio). For Aim 2, young adults vapers (N=360) and adult smokers (N=360) will administer an e-cigarette product and complete behavioral economic tasks that test the participant's choice of earning money to delay initiation and continued use of: (1) The sampled e-cigarette product (abuse liability; young adult vapers); or (2) Their own brand cigarettes (ability to resist smoking; adult current smokers). A pilot study will establish device and e-liquid parameters (e.g., nicotine concentration) to be used for all aims.

NCT ID: NCT03710590 Completed - Clinical trials for Electronic Cigarettes

Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.

NCT ID: NCT03435562 Completed - Clinical trials for Electronic Cigarettes

Assessment of Two New Electronic Cigarettes in Cigarette Smokers

Start date: March 3, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.

NCT ID: NCT03284632 Completed - Smoking Clinical Trials

e-Cigarette - DNA Adducts

Start date: July 11, 2017
Phase:
Study type: Observational

This study will examine the level of toxicity of e-cigarette use compared to smokers and nonsmokers including inflammation markers, toxicant and carcinogen exposure. Additionally, the study will look at the effect of varying voltage levels for e-cigarette users.

NCT ID: NCT03194256 Completed - Smoking, Cigarette Clinical Trials

Evaluating New Nicotine Standards for Cigarettes - Project 3

CENIC2-P3
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This study is designed to examine how the nicotine content of cigarettes and the nicotine concentration and flavors in e-liquids influence responses to and use of these products in adolescent smokers. Participants will complete a total of six sessions (an in-person screening/baseline session and five lab sessions.

NCT ID: NCT03098004 Completed - Clinical trials for Electronic Cigarettes

Effects of e-Cigarettes on Nicotine Withdrawal

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

This behavioral pharmacology laboratory experiment will assess whether sweet (vs. non-sweet) flavored e-cigarette solutions reduce tobacco withdrawal symptoms and motivation to smoke among 40 smokers interested in trying e-cigarettes (for the first time) following 16-hours of nicotine abstinence. The study's experimental design will provide evidence of the causal effects of e-cigarette flavorings on a putatively critical factor for determining whether smokers continue e-cigarette use after initial trial-the ability of a product to suppress withdrawal and motivation to smoke during periods of tobacco deprivation.